News
Needham Reiterates Buy on Immuneering, Maintains $15 Price Target
12 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Immuneering Presented Preclinical Data At AACR annual Meeting For Ongoing Phase 2a Clinical Trial Of IMM-1-104 In RAS-Mutated Advanced Or Metastatic Solid Tumors
9 Apr 24
Biotech, News, Events, General
Immuneering Announces First Patient Dosed In Its Phase 1/2a Trial Of IMM-6-415 To Treat Advanced Solid Tumors With RAF Or RAS Mutations
27 Mar 24
Biotech, News, General
Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
18 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Monday's Intraday Session
18 Mar 24
Movers
Cancer Treatment Focused Immuneering Faces Analyst Downgrades, Who Cite Underwhelming Solid Tumor Trial Data
15 Mar 24
Analyst Color, Biotech, News, Health Care, Price Target, Top Stories, Analyst Ratings, Movers, Trading Ideas, General
Dow Falls Over 200 Points; Adobe Shares Plunge
15 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session
15 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Friday's Intraday Session
15 Mar 24
Movers
Crude Oil Edges Lower; US Consumer Sentiment Falls In March
15 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Jefferies Downgrades Immuneering to Hold, Lowers Price Target to $3
15 Mar 24
News, Downgrades, Price Target, Analyst Ratings
Chardan Capital Maintains Buy on Immuneering, Lowers Price Target to $16
15 Mar 24
News, Price Target, Analyst Ratings
Needham Maintains Buy on Immuneering, Lowers Price Target to $15
15 Mar 24
News, Price Target, Analyst Ratings
TD Cowen Downgrades Immuneering to Market Perform
15 Mar 24
News, Downgrades, Analyst Ratings
Guggenheim Downgrades Immuneering to Neutral
14 Mar 24
News, Downgrades, Analyst Ratings
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
14 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Thursday's Intraday Session
14 Mar 24
Movers
What's Going On With Cancer-Focused Immuneering Stock On Thursday?
14 Mar 24
Biotech, News, Health Care, Movers, General
US Stocks Higher; Producer Prices Rise 0.6% In February
14 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Global, Intraday Update, Markets, Trading Ideas
Needham Reiterates Buy on Immuneering, Maintains $20 Price Target
11 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Press releases
IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models
9 Apr 24
Press Releases
Immuneering to Participate in the 23rd Annual Needham Virtual Healthcare Conference
3 Apr 24
News, Health Care, Press Releases
Immuneering Announces First Patient Dosed in its Phase 1/2a Trial of IMM-6-415 to Treat Advanced Solid Tumors with RAF or RAS Mutations
27 Mar 24
Press Releases
March Madness Market Movers: INBS, NCMI, CIFR, IMRX, STI
19 Mar 24
News, Press Releases
Immuneering Announces Positive Topline Results from Phase 1 Portion of its Phase 1/2a Clinical Trial of IMM-1-104 in RAS-Mutant Solid Tumors
14 Mar 24
News, Health Care, Press Releases
Immuneering to Present Preclinical Data on Universal-RAS Program IMM-1-104 at American Association for Cancer Research Annual Meeting 2024
5 Mar 24
News, Health Care, Press Releases
Immuneering Announces Participation in February Investor Conferences
1 Feb 24
News, Health Care, Press Releases